Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDK inhibitors
Biotech
Kronos lays off 83% of staff, changes CEO after clinical setback
Kronos is laying off 83% of its staff and ushering in an interim CEO next month as the biotech looks to recover from a recent fumble in the clinic.
Fraiser Kansteiner
Nov 27, 2024 9:56am
Genentech pays $850M upfront for Regor's CDK inhibitors
Sep 30, 2024 5:30am
Kronos launches second round of layoffs in 5 months
Mar 8, 2024 10:35am
BeiGene offers up $1.3B in biobucks for preclinical cancer drug
Nov 21, 2023 7:13am
Bayer inks Cedilla cancer deal to join pack chasing Pfizer
Jun 1, 2023 7:30am
Syros targets KRAS-mutant cancer with CDK7 inhibitor
Sep 20, 2021 11:30am
